23 related articles for article (PubMed ID: 46253)
1. Kinetics and localization of IgE tetanus antibody response in mice immunized by the intratracheal, intraperitoneal and subcutaneous routes.
Gerbrandy JL; Bienenstock J
Immunology; 1976 Dec; 31(6):913-9. PubMed ID: 992717
[TBL] [Abstract][Full Text] [Related]
2. Regulation of reaginic antibody production in mice. I. Suppression by antigen of IgE antibody production in vitro.
Danneman PJ; Michael JG
J Exp Med; 1977 Dec; 146(6):1534-48. PubMed ID: 562920
[TBL] [Abstract][Full Text] [Related]
3. Hapten specific unresponsiveness in mice. I. Characteristics of unresponsiveness induced by 2,4,6-trinitrobenzene sulphonic acid.
Huchet R; Grandjon D; Davies AJ
Immunology; 1979 Mar; 36(3):595-605. PubMed ID: 86508
[TBL] [Abstract][Full Text] [Related]
4. Suppression of reaginic antibody formation. III. Relationship between immunogenecity and tolerogenicity of hapten-carrier conjugates.
Lee WY; Sehon AH
J Immunol; 1976 Jun; 116(6):1711-8. PubMed ID: 58048
[TBL] [Abstract][Full Text] [Related]
5. Reaginic antibody formation in the mouse. V. Adoptive antihapten IgE antibody response of dinitrophenyl-keyhole limpet hemocyanin-primed spleen cells cultured with dinitrophenyl heterologous carrier conjugates.
Okudaira H; Ishizaka K
J Immunol; 1975 Feb; 114(2 Pt 1):615-20. PubMed ID: 47357
[TBL] [Abstract][Full Text] [Related]
6. Suppression of reaginic antibody formation. I. Induction of hapten-specific tolerance.
Lee WY; Sehon AH
J Immunol; 1975 Feb; 114(2 pt 2):829-36. PubMed ID: 46252
[TBL] [Abstract][Full Text] [Related]
7. [Suppression of reaginic antibodies].
Sehon AH; Lee WY
Ann Immunol (Paris); 1977; 128(1-2):457-68. PubMed ID: 848899
[TBL] [Abstract][Full Text] [Related]
8. Reaginic antibody formation in the mouse. VII. Induction of suppressor T cells for IgE and IgG antibody responses.
Takatsu K; Ishizaka K
J Immunol; 1976 May; 116(5):1257-64. PubMed ID: 1083868
[TBL] [Abstract][Full Text] [Related]
9. Suppression of reaginic antibody formation. II. The use of adoptive transfer system for the study of immunological unresponsiveness.
Lee WY; Sehon AH
J Immunol; 1975 Feb; 114(2 pt 2):837-42. PubMed ID: 46253
[TBL] [Abstract][Full Text] [Related]
10. T cell-dependent suppression of an anti-hapten antibody response.
Basten A; Miller JF; Johnson P
Transplant Rev; 1975; 26():130-69. PubMed ID: 52217
[No Abstract] [Full Text] [Related]
11. [Antibodies as regulators of induced biosynthesis of immunoglobulins (review)].
Prokopenko LG
Zh Mikrobiol Epidemiol Immunobiol; 1970 Oct; 47(10):98-102. PubMed ID: 4101403
[No Abstract] [Full Text] [Related]
12. Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies.
Kishimoto TK
Front Immunol; 2020; 11():969. PubMed ID: 32508839
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]